TÜBA Member Prof. Sancar's New Academic Year Opening Lecture at ITU
In his lecture, Sancar explained his work on how a molecule known as 'EDU' could provide a solution against brain cancer. Sancar and his team's work reveals the potential for a solution against brain cancer, which has a very high mortality rate.
The opening lecture of the 2024-2025 Academic Year held at Istanbul Technical University's (ITU) Ayazağa Campus Süleyman Demirel Cultural Center was given by Prof. Aziz Sancar, 2015 Nobel Prize winner in Chemistry and TÜBA Honorary Member. TÜBA President Prof. Muzaffer Şeker, ITU Rector Prof. Hasan Mandal, Vice Rectors, academic and administrative staff and students attended the ceremony.
Following ITU Rector Prof. Hasan Mandal's comprehensive presentation of ITU's current situation analysis and future goals, biochemist and molecular biologist Prof. Aziz Sancar delivered the opening lecture of the 2024-2025 Academic Year titled “EdU (5-etinil-2'-deoksiüridin) Beyin Kanseri Tedavisi İçin Potansiyel Bir Aday”(EdU (5-ethynyl-2'-deoxyuridine) as a Potential Candidate for Brain Cancer Treatment). Sancar stated that for the first time, the information he presented in the lecture was the results of his laboratory.
In the lecture, Prof. Sancar explained the studies he conducted to clarify the mechanism of action of EdU at the cellular level, which was previously not well known, and drew attention to the potential of EdU as a treatment agent that can cross the blood-brain barrier against aggressive brain cancers such as Glioblastoma without damaging nerve cells.
At the end of the lecture, TÜBA President Prof. Muzaffer Şeker presented congratulatory certificates to the winners of the 2024 TÜBA-TEKNOFEST Doctoral Science Awards.
